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OBJECTIVES: Vardenafil enhances dilatation of vascular smooth muscle and inhibits platelet aggregation. The
purpose of this study was to evaluate the clinical effects of vardenafil and pentoxifylline administration in an
experimental model of ischemic colitis.
METHODS: Forty female Wistar albino rats weighing 250–300 g were randomized into five experimental groups
(each with n = 8) as follows:1) a sham group subjected to a sham surgical procedure and administered only tap
water; 2) a control group subjected to a standardized surgical procedure to induce ischemic colitis and
administered only tap water; 3) and 4) treatment groups subjected to surgical induction of ischemic colitis
followed by the postoperative administration of 5 mg/kg or 10 mg/kg vardenafil, respectively; and 5) a
treatment group subjected to surgical induction of ischemic colitis followed by postoperative administration of
pentoxifylline at 50 mg/kg/day per day as a single dose for a 3-day period. All animals were sacrificed at 72 h
post-surgery and subjected to relaparotomy. We scored the macroscopically visible damage, measured the
ischemic area and scored histopathology to determine the severity of ischemia. Tissue malondialdehyde levels
were also quantified.
RESULTS: The mean Gomella ischemic areas were 63.3 mm2 in the control group; 3.4 and 9.6 mm2 in the
vardenafil 5 and vardenafil 10 groups, respectively; and 3.4 mm2 in the pentoxifylline group (p= 0.0001). The
mean malondialdehyde values were 63.7 nmol/g in the control group; 25.3 and 25.6 nmol/g in the vardenafil 5
and vardenafil 10 groups, respectively; and 22.8 nmol/g in the pentoxifylline group (p= 0.0001).
CONCLUSION: Our findings indicate that vardenafil and pentoxifylline are effective treatment options in an
animal model of ischemic colitis. The positive clinical effects produced by these drugs are likely due to their
influence on the hemodynamics associated with vascular smooth muscle and platelet functions.
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& INTRODUCTION
When oxygen and energy delivery is below the metabolic
requirement of the intestine or when there is mesenteric
circulation failure, the resultant condition is called mesen-
teric ischemia. Ischemic colitis (IC) is a type of mesenteric
ischemia involving failure in colonic circulation (1). IC is
one of the most common colon diseases affecting the elderly
population and the annual incidence rate in the general
population is 4.5-44/100.000. While the incidence of
ischemic colitis following elective aortic surgeries is 1-2%,
it increases to 60% following emergency surgeries (2). In
emergency surgeries, the mortality rate is 50–70%. Diabetes
mellitus, chronic renal failure, various rheumatic diseases,
vasculitis and renal transplantation are other known causes
of IC (3,4), which results from injury to the colonic wall,
leading to insufficient blood flow. The actual mechanism
responsible for the pathophysiology of IC is ischemia-
reperfusion damage. In most cases, colonic tissue hypoxia
results in local hypoperfusion. If not properly treated, this
may lead to multiple organ dysfunction (4,5). The majority
of IC cases are asymptomatic. Clinical presentation usually
begins with sudden cramping and abdominal pain, mostly
localized in the left lower quadrant and an intense need to
defecate. Within 24 hours, bright red or maroon-colored
stools mixed with blood are observed (1,3). Physical
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examination findings include mild to moderate degrees of
sensitivity in the intestinal segment, abdominal distension,
mild fever, tachycardia and positive test results for occult
blood in stool samples. In 10-20% of cases, signs of
peritoneal irritation may occur, depending on the develop-
ment of necrosis in the colon. The emergence of peritoneal
irritation in acute onset ischemic colitis indicates the
development of gangrene or perforation and requires
explorative laparotomy (1,2,4,6). No published studies have
provided a sufficient level of evidence to create an
appropriate treatment model for IC (7). A majority of the
literature describes IC cases associated with mesenteric
infarction. Some retrospective studies have focused on
specific treatments and have concluded that an extended
colectomy or surgery is not recommended in most cases. In
serious cases, prolonged surgery and aggressive surgery are
recommended to reduce mortality (8). PDE–5 inhibitors are
used to induce dilatation of the vascular smooth muscle and
to inhibit platelet aggregation in the treatment of erectile
dysfunction and testicular torsion (24), pulmonary hyper-
tension (37), coronary artery disease, diabetes mellitus
(38), deep vein thrombosis and in anti-anginal therapy
(39). Vardenafil is a phosphodiesterase-5 inhibitor (9).
Pentoxifylline (PTX) and its metabolites increase the blood
fluidity by reducing blood viscosity. By increasing micro-
circulatory blood flow, these drugs have a positive effect on
the oxygen uptake of tissue and are thus used to treat
patients with chronic peripheral arterial diseases (10).
Considering the above, we hypothesized that vardenafil
and pentoxifylline might be effective treatment options in
models of ischemic colitis. The purpose of this study was to
evaluate the therapeutic effects of vardenafil and pentoxifyl-
line administration in an experimental rat model of ischemic
colitis.
& MATERIALS AND METHODS
Ethics
This experimental study was conducted at the Marmara
University School of Medicine Experimental and Animal
Research Center (DEHAMER) between January and June
2013. The study was approved by the Ethics Committee of
the Faculty of Medicine (dated 5/27/2013 with Ethics
Committee approval n .˚ 332.2013.Mar).
Animals
Forty 28–32-week-old female albino Wistar rats, ranging
in weight from 200 g to 250 g, were evaluated. The rats were
maintained under a 12-hour/12-hour light/dark cycle; they
were housed three to a cage at maximum and kept at a room
temperature of approximately 23¡2 C˚. Throughout the
study, the rats were provided with aged tap water (rested
tap water) and standard pellet feed.
Experimental design and administration of drugs
A homogeneous solution was prepared by dissolving
vardenafil (Levitra; Bayer, U¨mraniye-I˙stanbul) tablets
(10 mg) in water. The first round of drug administration
occurred via orogastric tube within 2 hours after surgery.
Pentoxifylline (Hemopene, Ibrahim Etem, Topkapi-
Istanbul) ampoules (100 mg, 5 cc) were mixed with physio-
logical saline solution and subsequently administered
intramuscularly at 50 mg/kg/day. The drug was also
administered intramuscularly following surgery. The study
animals were sacrificed at 3 days post-surgery using
cervical dislocation and U-shaped incisions were used to
open their abdominal cavities. Colonic structures were
removed for macroscopic and microscopic evaluation and
the necessary scoring was performed (Table 1).
The animals were randomized into five experimental
groups (each with n = 8). Group 1 animals were subjected to
a sham operation (n = 8) and received only tap water. Group
2 animals were subjected to surgical induction of IC and
also received only tap water. Group 3 and group 4 animals
were subjected to surgical induction of IC and received
either 5 mg/kg/body weight or 10 mg/kg/body weight
oral vardenafil, respectively. Group 5 animals were sub-
jected to surgical induction of IC and received 50 mg/kg/
body weight intramuscular PTX. The indicated drug was
administered to all treatment groups as a single daily dose
for 3 days.
Surgical procedure
During surgery, anesthesia was administered intraper-
itoneally at doses of 50 mg/kg (for ketamine) and 10 mg/kg
(for chlorpromazine). Rats were shaved following the
administration of anesthesia and the skin was prepared
with 10% povidone-iodine. The method described by
Griffen and Hagihara (11) was used to induce experimental
IC (Figure 1). According to this method, a median
laparotomy was performed, the left colon was carefully
removed from the abdomen and ischemic colitis was
induced by connecting the marginal arteries of the 4-cm-
long segment of the left colon at two separate places and all
of the vasa recta with 4/0 silk (Ethicon, Edinburgh, UK;
Figure 1). The left colon was then anatomically placed into
the abdomen and the abdomen was closed via continuous
suturing using 3/0 silk sutures (Silk, Dogsan, Istanbul,
Turkey).
The animals were returned to their cages upon regaining
consciousness and were allowed to drink water and eat.
At 72 hours post-surgery, the animals were euthanized
Table 1 - Management of the ischemic colitis rat model.
Groups Operation Procedure Euthanasia
Sham group n:8 Only laparotomy Oral 10 mg/kg 0.9% NaCl at the same time
for 3 days
Cervical dislocation with 50 mg/kg
ketamine after 72 hours.
Control group n:8 Laparotomy and IC model Oral 10 mg/kg 0.9% NaCl at the same time
for 3 days
Vardenafil 5 mg group n:8 Laparotomy and IC model Oral 5 mg/kg vardenafil at the same time
for 3 days
Vardenafil 10 mg group n:8 Laparotomy and IC model Oral 10 mg/kg vardenafil at the same time
for 3 days
Pentoxifylline group n:8 Laparotomy and IC model I.M. 50 mg/kg PTX at the same time for 3 days
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(cervical dislocation) under anesthesia and relaparotomy was
performed. Colonic tissues were resected for examination.
There were no observable fistula or perforations in the
binding sites of the marginal artery and branches of the colon.
Macroscopic evaluation of the damage
Prior to euthanasia, the rats were anesthetized and
reopened via median laparotomy. The abdominal cavities
were examined to determine the presence of acidic liquid,
intestinal dilatation, serosal change and perforation. The
devascularized segment of the colon was excised and
opened longitudinally from the antimesenteric side.
A pathologist who was blinded to the sample origin
examined the collected tissues. Ischemic changes in the
colonic mucosa (excised according to the method of Gomella
et al. (12)) were examined on clean graphene paper. The
following scoring system developed by Wallace (13) was
used to assess the severity of macroscopically visible damage
(MVD): 0, normal; 1, local ischemia without ulceration; 2,
ulceration without hyperemia; 3, ulceration (+) and hyper-
emia in the area; 4, ulceration (#2 cm; +) and hyperemia in
the area; 5, .2 cm ulcers in many areas (13) (Figure 2).
Histopathological analysis
A histopathological examination was performed at the
Marmara University School of Medicine, Department of
Pathology. Tissue samples from the left colon that were
fixed in a 10% formaldehyde solution were divided into
5 mm pieces and separated for examination. A pathologist
who was blinded to sample origin examined the collected
tissues. Histopathological analysis and measurement of the
severity of ischemic damage were performed using the
following ischemic damage classification system developed
by Chiu (14): 0, normal mucosal villus; 1, subepithelial
Gruenhagen’s area congestion; 2, epithelial layer moder-
ately separated from the lamina propria, 3, massive
epithelial separation of villus slices and peeling in a few
places; 4, villus separated from lamina propria and
stretched with dilated capillaries; 5, digested and diffuse
lamina propria with bleeding and ulceration.
Measurement of malondialdehyde in tissue
Malondialdehyde (MDA) is a secondary product of lipid
peroxidation and is thus used as a parameter to determine
the extent of lipid peroxidation. Uchiyama and Mihara (15)
described how MDA measurements can be used to assess
the levels of oxidative damage within tissues. In our study,
colonic tissues were frozen at -20 C˚ and malondialdehyde
content was quantified. The tissue samples were homo-
genized in 50 mmol Tris-HCl (pH 7.4) containing 180 mmol
KCL and 10 mmol EDTA and subsequently weighed. The
MDA concentration was analyzed via high-performance
liquid chromatography (HPLC).
Statistical analysis
The data obtained in this study were analyzed using the
SPSS 20 Package (Statistical Package for the Social Sciences,
Chicago, IL). Paired group comparisons were performed
using the Mann-Whitney U test and the Bonferroni-
corrected Kruskal-Wallis H test was employed for compar-
isons involving 3 or more groups. The results are expressed
as the mean ¡ standard deviation (min-max). The correla-
tion between the variables was examined using Fisher’s
Exact Test. P-values of ,0.05 indicated a significant
difference. The Bonferroni test was utilized for multiple
comparisons and p,0.01 was considered statistically sig-
nificant.
& RESULTS
None of the rats died during the study.
Macroscopic damage
The statistical comparison between sham and control
groups, significant differences were found with respect to
the presence of acidic liquid, bowel dilatation and serosal
changes (p,0.05). However, no significant differences were
observed when comparing either perforation or adhesion
between these groups (p.0.05). In comparing the vardenafil
5 mg and 10 mg groups and the pentoxifylline group with
the control group, significant differences were found with
respect to the presence of acidic liquid, bowel dilatation and
serosal changes (p,0.05; Table 2).
Macroscopic damage was measured according to the
method described by Gomella et al. (12). The ischemic areas
were 63.3 mm2 in the control group, 3.4 and 9.6 mm2 in the
vardenafil 5 mg and 10 mg groups, respectively and
2.8 mm2 in the PTX group. A significant difference was
observed when comparing the Gomella ischemic areas
(p= 0.0001) of the sham and control groups. Comparison
of the vardenafil 5 mg and 10 mg groups and the
pentoxifylline group with the control group also revealed
significant differences in Gomella ischemic areas (p= 0.0001;
Table 3).
We also evaluated the colonic mucosa to identify
hyperemia, ulceration and inflammation, and resected
colons were macroscopically evaluated using the Wallace
macroscopic damage scoring system (13). A significant
difference was observed in the average Wallace scores
obtained for the sham and control groups (p,0.01).
Comparison of the vardenafil 5 mg and 10 mg groups and
the pentoxifylline group with the control group also
revealed a significant difference in the average Wallace
score (p,0.01). However, there were no statistically sig-
nificant differences in the average Wallace scores between
the vardenafil 5 mg and 10 mg groups or between the
vardenafil groups and the pentoxifylline group (p.0.01;
Table 3).
Figure 1 - Ischemic colitis model.
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Histopathological evaluation
We employed the ischemic damage classification system
developed by Chiu (14) to perform histopathological evalua-
tion of the resected tissues. A significant difference was found
between the average Chiu scores of the sham and control
groups (p,0.01). Statistically significant differences (p,0.01)
were also found when comparing the average Chiu scores of
the vardenafil 5 mg and 10 mg groups or the pentoxifylline
group to that of the control group. However, there was no
statistically significant difference observed in the average
Chiu scores of the vardenafil groups or between the vardenafil
groups and the pentoxifylline group (Table 3) (Figure 3).
Measurement of malondialdehyde in tissue (MDA)
The mean MDA values were 18 and 63.7 nmol/g in the
sham and control groups, respectively; 25.3 and 25.6 nmol/g
in the vardenafil 5 mg and 10 mg groups, respectively; and
22.7 nmol/g in the pentoxifylline group. A significant differ-
ence was found in the mean MDA values (p= 0.0001) of the
sham and control groups. When comparing the vardenafil
5 mg and 10 mg groups and the pentoxifylline group to the
control group, significant differences in mean MDA values
were also observed (p= 0.0001; Table 3).
& DISCUSSION
Ischemic colitis is the most common ischemic colon
disease (1,2). Boley et al. (3) were the first to describe
ischemic colitis in the 1960 s. The annual incidence rate of IC
is 4.5-44/100,000 individuals in the general population and
the disease is present in 1 out of every 2000 patients
admitted to emergency units (1-3). IC frequently occurs
following aortic surgery and abdominal aortic surgery (3,4);
it generally results from colonic damage as a result of
hypoperfusion and has various causes. The main factor
leading to colonic damage is a decrease in oxygen diffusion
due to insufficient tissue perfusion (16,17,39). IC occurs
most commonly in the left colon, especially in the splenic
flexure. The incidence rate in the right colon is also
gradually increasing. The splenic flexure has the disadvan-
tage of limited blood flow, as it is located between two
mesenteric arteries that in effect function as a ‘‘watershed
area’’ (18). While ischemia may only affect the mucosa,
transmural colitis can affect all layers of the colon and lead
to stricture. In fulminant cases, it may further progress and
cause gangrene (16-18). Experimental studies have demon-
strated that colonic damage caused by microcirculation
disorders is similar to that caused by ischemic colitis in
humans (19).
The clinical spectrum of IC is broad, varying from the self-
limiting mild form to the fast-progressing life-threatening
form (1,2). Symptomology frequently includes the sudden
onset of abdominal pain, nausea, vomiting and diarrhea
(often bloody). Systemic inflammatory response syndrome
(SIRS), abdominal distention and abdominal tenderness
may also occur. In the mild form of IC, the mucosa and the
Table 2 - Comparison of macroscopic damage between groups.
Acidic liquid
Bowel
dilatation Serosal changes Perforation Adhesion
GROUPS No Yes No Yes No Yes No Yes No Yes
A = Sham group n 8 0 8 0 8 0 8 0 8 0
% 100 0 100 0 100 0 100 0 100 0
B = Control group n 0 8 0 8 0 8 5 3 0 100
% 0 100 0 100 0 100 62.5 37.5 0 100
C = Vardenafil 10 mg group n 5 3 6 2 6 2 8 0 2 6
% 62.5 37.5 75 25 75 25 100 0 25 75
D = Vardenafil 5 mg group n 6 2 5 3 8 0 8 0 2 6
% 75 25 62.5 37.5 100 0 100 0 25 75
E=Pentoxifylline group n 8 0 6 2 8 0 8 0 3 5
% 100 0 75 25 100 0 100 0 37.5 62.5
Statistics p and binary
comparison
A-B (0,001),
B-C (0.026),
B- (0.007),
B- (0.0001)
A-B (0.001),
B-C (0.007),
B-D (0.026),
B-E (0.007)
A-B (0.0001),
B-C (0.007),
B-D, (0001),
B- (0.0001)
A-B (0.201),
B-C (0.201),
B-D (0.201),
B-E (0.201)
A- (0.467),
B-C (0.467),
B-D (0.467),
B-E (0.201)
Table 3 - Comparisons of MDA, Wallace macroscopic damage scores and Chiu classification in rats.
MDA
(nmol/gr)
Wallace macroscopic damage scoring
(MVD) Chiu classification
Gomella
ischemic
areas (IAs)
(mm2)Groups n 0 1 2 3 4 5 0 1 2 3 4 5
A = Sham group 8 18.0 8 0 0 0 0 0 8 0 0 0 0 0 0.0
B = Control group 8 63.7 0 1 3 2 1 1 0 1 3 0 1 3 63.3
C = Vardenafil 10 mg 8 25.6 2 5 1 0 0 0 2 5 0 1 0 0 9.6
D = Vardenafil 5 mg 8 25.3 2 6 0 0 0 0 3 5 0 0 0 0 3.4
E = Pentoxifylline group 8 22.7 3 5 0 0 0 0 3 5 0 0 0 0 2.8
Binary group comparisons
(p-value)
A-B,
B-C,
B-D,
B-E
(p= 0.0001)
A-B (0.0001), A-C (0.003), A-D (0.003),
A-E (0.009), B-C (0.003), B-D (0.001),
B-E (0.001), C-D (0.679), C-E (0.424),
D-E (0.602)
A-B (0.0001), A-C (0.003), A-D (0.009),
A-E (0.009), B-C (0.006), B-D (0.001),
B-E (0.001), C-D (0.424), C-E (0.424),
D-E (0.333)
A-B, A-C,
A-D, A-E,
B-C, B-D,
B-E
p= 0.0001
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submucosa are damaged; however, the damage is limited
and generally responds to medical intervention. Oral
feeding is interrupted, the intestines are allowed to rest
and supportive drug treatment may be initiated using
parenteral antibiotics administered via a nasogastric tube
(1,2,4,5,7). In severe forms of IC, the colon is completely
damaged, patient prognosis is poor and surgical treatment
is often required (20,21). PDE–5 inhibitors induce vascular
smooth muscle dilatation and inhibit platelet aggregation by
preventing the breakdown of nitric oxide (NO)-dependent
cGMP. Vardenafil, sildenafil and tadalafil are potent PDE-5
inhibitors that can be used in the treatment of erectile
dysfunction, pulmonary artery hypertension, coronary
artery disease, diabetes mellitus, testicular torsion, deep
vein thrombosis, anti-anginal therapy (39) and acute renal
ischemia (22,23,36).
Hotta et al. (24) demonstrated the efficacy of vardenafil in
the treatment of acute arterial erectile dysfunction in rats.
PTX inhibits microvascular construction and blocks
erythrocyte and platelet aggregation. It also increases
fibrinolysis and suppresses leukocyte hyperactivity by
reducing superoxide release and neutrophil adhesion
(10,33). In an experimental study, Parra-Membrives et al.
(25) demonstrated that pentoxifylline administration has a
positive impact on the recovery of ischemic anastomosis by
reducing anastomotic leakage and increasing bursting
pressure. Moreover, Tireli et al. (26) showed that pentoxifyl-
line reduces ischemic reperfusion injury in small intestine
anastomosis through its additive effect on collagen synth-
esis and anastomotic strength. Additionally, PTX may be
used to treat a variety of disorders including vasoocclusive
diseases (10), infectious diseases (33), immune deficiencies
(34) and hypercoagulation (35).
Platelet activating factor (PAF), which leads to vasocon-
striction with vasoactive properties and tissue hypoperfu-
sion, causes a gastrointestinal mucosal ulceration. Many
researchers have shown that PAF might cause mucosal
damage within the gastrointestinal tract (27).
Adams et al. (33) investigated the effect of pentoxifylline
in an ischemic reperfusion model. In this study, the efficacy
of pentoxifylline was demonstrated based on the resulting
inhibition of platelet-activating factor.
Studies have shown that PDE inhibitors and NO-
dependent cGMP protein kinases play an important role
Figure 2 - Measurement of ischemic areas in the control group.
Figure 3 - Group histopathology. A. Common massive areas of epithelial detachment and presence of transmural necrosis. [‘‘Chiu’’
classification grade 5] (H&E x40). B. Massive areas of epithelial detachment (shown with an arrow) [‘‘Chiu’’ classification grade 3] (H&E
x100). C. Subepithelial ‘‘Gruenhagen’s space’’ (shown with an asterisk) and capillary congestion (shown with an arrow) [‘‘Chiu’’
classification grade 1] (H&E x200). D. Area of mucosal ischemic necrosis (H&E x200).
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in platelet inhibition. Vardenafil and sildenafil are expected
to correct potential platelet inhibition and microcirculation
(28).
In a postoperative skin flap viability study conducted by
Sarifakiog˘lu (28) and Hart et al. (29) were demonstrated
significant improvement due to platelet inhibition and
sildenafil-related vasodilatation. Moreover, the efficacy of
vardenafil and other PDE-5 inhibitors has been demon-
strated in the treatment of pulmonary arterial hypertension
(30) as well as in studies of lung contusion (31), testicular
torsion and radical prostatectomy (32). In the present study,
we considered these properties of vardenafil and other
PDE–5 inhibitors as a starting point, compared their effects
with the proven effects of PTX and investigated the efficacy
of vardenafil administration in an animal model of IC.
In routine clinical studies, many patients diagnosed with
IC are admitted to hospitals; however, the use of vardenafil
in these patients has been limited.
In the present study, we successfully employed the
experimental model of ischemic colitis as described by
Griffen and Hagihara (11).
In comparing our sham group to the control group, we
found statistically significant differences in the mean MDA
values (15) of macroscopic damage scores (MVD) (used by
Irkorucu et al. (9) and described by Wallace et al. (13)) as
well as in the Gomella ischemic area (12) and Chiu
classification (14). These differences illustrated the suitabil-
ity of our model system.
In our ischemic colitis model, rats were administered
vardenafil at 5 mg or 10 mg and the macroscopic damage
scores, Gomella ischemic areas (12) and mean MDA values
(15) were used as biochemical parameters of therapeutic
outcome. Additionally, histopathological measurements
were evaluated using the Chiu classification system (14).
The resulting data revealed significant differences between
the treatment and control groups. These results indicate that
vardenafil administration is an effective strategy overall and
the two different doses of vardenafil evaluated in this study
were therapeutically equivalent.
Pentoxifylline (PTX) is a drug with proven efficacy in
clinical practice (33-35). In our ischemic colitis rat model, we
administered PTX and evaluated several biochemical para-
meters including macroscopic damage scores (13), Gomella
ischemic areas (12) and mean MDA values (15) to quantify
therapeutic efficacy. We also employed the Chiu classifica-
tion (14) for histopathological evaluation. Statistically sig-
nificant differences were observed between the PTX,
treatment group and the control group, demonstrating that
PTX may be an effective clinical option.
The limitations of this study include the fact that we did
not analyze acute phase reactants or cytokines (IL-1, 6, TNF-
a) and we did not study any alternative PDE-5 inhibitors.
The relative efficacies of vardenafil versus PTX adminis-
tration were evaluated in an ischemic colitis rat model.
Morphological and biochemical data obtained from the
treatment groups were statistically comparable and sig-
nificant differences were noted when compared to the
control group. These results demonstrate that both varde-
nafil and pentoxifylline are effective therapeutic options for
this IC model and there is no significant difference between
the effects of these two pharmacological agents.
Our study results demonstrated that vardenafil and
pentoxifylline are effective therapeutic options in a rat
model of IC. These results are likely due to the positive
effect that these drugs exert on the hemodynamics
associated with vascular smooth muscle and platelet
functions. Vardenafil and PTX might therefore be useful
treatment options in models of mesenteric ischemia and
vasospastic disease. Our hope is that the results of the
current study, combined with those of additional studies,
will lead to future clinical utilization of vardenafil and other
PDE-5 inhibitors in the treatment of ischemic colitis.
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